![]() |
![]() |
Legal status
Patent revoked (after opposition at EPO)
(51) | INT.CL. | A61K 31/436 | (2006.01) |
A61K 31/365 | (2006.01) | ||
A61K 31/351 | (2006.01) | ||
A61P 35/00 | (2006.01) | ||
A61P 25/00 | (2006.01) |
(11) | Number of the document | 1983984 |
(13) | Kind of document | T |
(96) | European patent application number | 07711417.1 |
Date of filing the European patent application | 2007-01-31 | |
(97) | Date of publication of the European application | 2008-10-29 |
(45) | Date of publication and mention of the grant of the patent | 2018-03-07 |
(46) | Date of publication of the claims translation | 2018-06-11 |
(86) | Number | PCT/EP2007/000818 |
Date | 2007-01-31 |
(87) | Number | WO 2007/088034 |
Date | 2007-08-09 |
(30) | Number | Date | Country code |
0602123 | 2006-02-02 | GB | |
0603568 | 2006-02-22 | GB | |
0604593 | 2006-03-07 | GB | |
0605760 | 2006-03-22 | GB | |
0609698 | 2006-05-16 | GB |
(72) |
BERG, William, US
BENEDETTO, John, US
ELMROTH, Ingrid, CH
LANE, Heidi, CH
LEBWOHL, David, US
SELLERS, William, US
STUMM, Michael, CH
|
(73) |
Novartis Pharma AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
(74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Tuberozinės sklerozės gydymas |
TUBEROUS SCLEROSIS TREATMENT |
Payment date | Validity (years) | Amount | |
2023-01-20 | 17 | 347.00 EUR |
Patent revoked (after opposition at EPO) | ||
Invalidation date | 2023-10-31 |